{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:18:19Z","timestamp":1789183099660,"version":"build-2803163510"},"reference-count":56,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,3,9]],"date-time":"2009-03-09T00:00:00Z","timestamp":1236556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was to investigate the effect of misoprostol, silymarin or the co\u2010administration of misoprostol\u2003+\u2003silymarin on the carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>)\u2010induced hepatic injury in rats. Misoprostol (10, 100, 1000\u2003\u03bcg\/kg), silymarin (25\u2003mg\/kg) or misoprostol (100\u2003\u03bcg\/kg)\u2003+\u2003silymarin (25\u2003mg\/kg) was given once daily orally simultaneously with CCl<jats:sub>4<\/jats:sub>and for 15\u2003days thereafter. The results showed that misoprostol (10, 100 or 1000\u2003\u03bcg\/kg) conferred significant protection against the hepatotoxic actions of CCl<jats:sub>4<\/jats:sub>in rats, reducing serum alanine aminotransferase (ALT) levels by 24.7%, 42.6% and 49.4%, respectively compared with controls. Misoprostol, given at 100 or 1000\u2003\u03bcg\/kg, decreased aspartate aminotransferase (AST) by 28 and 43.6% and alkaline phosphatase (ALP) by 19.3% and 53.4% respectively. Meanwhile, silymarin reduced ALT, AST and ALP levels by 62.7%, 66.1% and 65.1% respectively. The co\u2010administration of misoprostol (100\u2003\u03bcg\/kg) and silymarin (25\u2003mg\/kg) resulted in 61.4%, 66.1% and 57.5% reduction in ALT, AST and ALP levels respectively. Histopathological alterations and depletion of hepatocyte glycogen and DNA content by CCl<jats:sub>4<\/jats:sub>were markedly reduced after treatment with misoprostol, silymarin or misoprostol\u2003+\u2003silymarin. Image analysis of liver specimens revealed a marked reduction in liver necrosis; area of damage: 32.4%, 24% and 10.2% after misoprostol (10, 100 or 1000\u2003\u03bcg\/kg), 7.2% after silymarin and 10.9% after treatment with misoprostol 100\u2003\u03bcg\/kg\u2003+\u2003silymarin, compared with CCl<jats:sub>4<\/jats:sub>control group (46.7%). These results indicate that treatment with misoprostol protects against hepatocellular necrosis induced by CCl<jats:sub>4<\/jats:sub>. This study suggests a potential therapeutic use for misoprostol in liver injury.<\/jats:p>","DOI":"10.1111\/j.1472-8206.2008.00654.x","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T01:50:19Z","timestamp":1236649819000},"page":"179-188","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Hepatoprotective effects of misoprostol and silymarin on carbon tetrachloride\u2010induced hepatic damage in rats"],"prefix":"10.1111","volume":"23","author":[{"given":"Omar M.E. Abdel","family":"Salam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany A.","family":"Sleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enayat A.","family":"Omara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila S.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,18]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7548.1013"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1002\/hep.1840360730","article-title":"Side effects of therapy of hepatitis C and their management","volume":"36","author":"Fried M.W.","year":"2002","journal-title":"Hepatology"},{"key":"e_1_2_5_6_2","first-page":"S30","article-title":"Managing hepatitis C","volume":"10","author":"Bacon B.R.","year":"2004","journal-title":"Am. J. Manage. Care"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161140-00003"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200222010-00007"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260316"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1999.0575"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655298750026543"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80285-7"},{"key":"e_1_2_5_13_2","first-page":"120","article-title":"Treatment of alcoholic hepatitis with silymarin. A double\u2010blind comparative study in 116 patients","volume":"13","author":"Trinchet J.C.","year":"1989","journal-title":"Gastroenterol. Clin. Biol."},{"key":"e_1_2_5_14_2","first-page":"456","article-title":"A pilot study on the liver protective effect of silybin\u2010phosphatidylcholine complex (IdB1016) in chronic active hepatitis","volume":"31","author":"Buzzelli G.","year":"1993","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04138.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0158fje"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2005.05.006"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-4-199308150-00001"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.40.148"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-6980(99)00059-3"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00094-6"},{"key":"e_1_2_5_22_2","first-page":"526","article-title":"Impact of selective prostaglandin E1 treatment on graft perfusion and function after liver transplantation","volume":"51","author":"Kornberg A.","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.03.046"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2006.21.5.897"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.500010506"},{"key":"e_1_2_5_26_2","first-page":"187","article-title":"Effect of misoprostol in ethanol\u2010induced liver injury","volume":"46","author":"Flisiak R.","year":"1995","journal-title":"Pol. J. Pathol."},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21493"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000129038"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000177817"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401163"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30542"},{"key":"e_1_2_5_32_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/9780470516751","volume-title":"Hepatotoxicity: from genomics to in vitro and in vivo models","author":"Sahu S.C.","year":"2007"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310006063"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(98)00179-3"},{"key":"e_1_2_5_35_2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/clinchem\/13.6.482","article-title":"The Reitman\u2010Frankel colorimetric transaminase procedure in suspected myocardial infarction","volume":"13","author":"Crowley L.V.","year":"1967","journal-title":"Clin. Chem."},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000459586"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2006.05.009"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1006\/mvre.2002.2404"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220625"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2006.02.003"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(06)60019-2"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx0155505"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-006-1506-8"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.3.1843"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2000.182"},{"key":"e_1_2_5_46_2","first-page":"11","article-title":"Effects of prostaglandin E1 infused via the superior mesenteric artery on partially resected, dearterialized canine liver","volume":"49","author":"Huang H.M.","year":"2003","journal-title":"Osaka City Med. J."},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.2174\/138161206777947678"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-483X(03)00157-4"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/713611034"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/jat.2550100408"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70565-2"},{"key":"e_1_2_5_52_2","first-page":"11","article-title":"Comparative effects of colchicine and silymarin on CCl4\u2010chronic liver damage in rats","volume":"28","author":"Favari L.","year":"1997","journal-title":"Arch. Med. Res."},{"key":"e_1_2_5_53_2","first-page":"611","article-title":"Silymarin mediated differential modulation of toxicity induced by carbon tetrachloride, paracetamol and d\u2010galactosamine in freshly isolated rat hepatocytes","volume":"35","author":"Chrungoo V.J.","year":"1997","journal-title":"Indian J. Exp. Biol."},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00148-9"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1996.tb06014.x"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.5414\/CPP40002"},{"key":"e_1_2_5_57_2","first-page":"1655","article-title":"Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C","volume":"141","author":"Par A.","year":"2000","journal-title":"Orv. Hetil."}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.2008.00654.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.2008.00654.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T04:24:58Z","timestamp":1738988698000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.2008.00654.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,18]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1472-8206.2008.00654.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.2008.00654.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,18]]},"assertion":[{"value":"2009-03-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}